A.J. Rice

Stock Analyst at UBS

(2.61)
# 839
Out of 5,266 analysts
261
Total ratings
58.87%
Success rate
18.77%
Average return
46 Stocks
Name Action Price Target Current % Upside Ratings Updated
Pediatrix Medical Gr...
Maintains: Neutral
17 19
16.21 14.13% 16 Feb 21, 2025
Community Health Sys
Maintains: Neutral
5 5
3.58 14.53% 6 Feb 20, 2025
BrightSpring Health
Maintains: Strong Buy
22 30
19.89 50.83% 4 Jan 29, 2025
Select Medical Hldgs
Maintains: Neutral
40 21
17.7 18.64% 7 Jan 3, 2025
Centene
Upgrades: Buy
79 80
57.49 39.15% 15 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
26
32.15 -19.13% 1 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
175
126.61 38.22% 1 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
197 217
131.04 65.6% 9 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
605 555
383.93 44.56% 2 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
38
25.53 48.84% 1 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
13.03 283.73% 1 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
247 267
180.24 48.14% 13 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
66 65
26.64 143.99% 9 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
2 3
4.4 -36.36% 6 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
83 85
79.17 7.36% 11 May 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
n/a n/a 2 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
10
8.22 15.57% 2 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
11 13
10.62 22.41% 10 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
22
18.05 21.88% 6 Nov 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
250 50
n/a n/a 3 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
450 485
597.71 -18.86% 1 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
95
40.26 135.97% 13 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
311 316
317.5 -0.47% 12 Jul 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 96
63.63 50.87% 6 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
62 73
98.27 -25.71% 8 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
635 575
258.39 122.53% 9 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
38
18.7 103.21% 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
590 610
458.79 32.96% 12 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
308 305
248.19 22.89% 4 Nov 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
64 79
127.07 -37.83% 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
175 182
n/a n/a 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
350 410
282.71 45.02% 3 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18
n/a n/a 1 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
43 37
6.17 499.68% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
158 143
170.74 -16.25% 9 Jul 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 43
10.22 320.74% 7 Jul 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 37
31.07 19.09% 3 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
181 182
90.41 101.31% 5 Apr 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
181 170
n/a n/a 4 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 270
300.89 -10.27% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
382 425
n/a n/a 7 Apr 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
27.18 -97.9% 3 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
4
n/a n/a 1 Jan 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
207 205
n/a n/a 7 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 65
n/a n/a 5 Jul 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 44
n/a n/a 2 Jan 31, 2018